Solara Active Pharma Sciences Ltd

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we wish to inform that based on the recommendation of the Audit Committee the Board of Directors of the Company at its meeting held today i.e. May 12 2023 has subject to the approval of the members of the Company to be obtained in the ensuing Annual general meeting of the Company recommended the re-appointment of Deloitte Haskins & Sells LLP Chartered Accountants (Firm Registration Number: 117366W/W-100018) as the Statutory Auditors of the Company under Section 139 of the Companies Act 2013.